Nationwide Fund Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-62,176
| Closed | -$3.36M | – | 2670 |
|
|
2017
Q3 | $3.36M | Buy |
62,176
+10,526
| +20% | +$569K | 0.01% | 1201 |
|
|
2017
Q2 | $2.9M | Buy |
51,650
+8,587
| +20% | +$482K | 0.01% | 1270 |
|
|
2017
Q1 | $1.69M | Sell |
43,063
-2,135
| -5% | -$83.7K | 0.01% | 1484 |
|
|
2016
Q4 | $1.01M | Sell |
45,198
-1,721
| -4% | -$38.6K | ﹤0.01% | 1774 |
|
|
2016
Q3 | $1.07M | Hold |
46,919
| – | – | ﹤0.01% | 1747 |
|
|
2016
Q2 | $1.11M | Sell |
46,919
-54
| -0.1% | -$1.27K | ﹤0.01% | 1676 |
|
|
2016
Q1 | $974K | Buy |
46,973
+83
| +0.2% | +$1.72K | ﹤0.01% | 1739 |
|
|
2015
Q4 | $2.41M | Buy |
46,890
+2,590
| +6% | +$133K | 0.01% | 1278 |
|
|
2015
Q3 | $1.89M | Sell |
44,300
-692
| -2% | -$29.5K | 0.01% | 1397 |
|
|
2015
Q2 | $2.05M | Sell |
44,992
-8,122
| -15% | -$370K | 0.01% | 1410 |
|
|
2015
Q1 | $2.02M | Buy |
53,114
+3,780
| +8% | +$143K | 0.01% | 1471 |
|
|
2014
Q4 | $1.4M | Buy |
49,334
+4,189
| +9% | +$119K | 0.01% | 1621 |
|
|
2014
Q3 | $1.14M | Buy |
45,145
+21
| +0% | +$531 | ﹤0.01% | 1760 |
|
|
2014
Q2 | $1.32M | Buy |
45,124
+19,799
| +78% | +$578K | 0.01% | 1716 |
|
|
2014
Q1 | $656K | Buy |
25,325
+2,090
| +9% | +$54.1K | ﹤0.01% | 1930 |
|
|
2013
Q4 | $598K | Buy |
23,235
+15,538
| +202% | +$400K | ﹤0.01% | 2159 |
|
|
2013
Q3 | $206K | Buy |
7,697
+4,598
| +148% | +$123K | ﹤0.01% | 2642 |
|
|
2013
Q2 | $76K | Buy |
+3,099
| New | +$76K | ﹤0.01% | 2878 |
|